International Journal of Clinical Research
International Journal of Clinical Research. 2026; 10: (3) ; 10.12208/j.ijcr.20260136 .
总浏览量: 27
1济宁医学院 山东济宁
2济宁医学院附属医院儿科 山东济宁
*通讯作者: 李秋波,单位:济宁医学院附属医院儿科 山东济宁; ;
本文报道1例10月龄男性先证者,因无热惊厥就诊,伴智力及运动发育落后,经多药调整仍有癫痫发作,且存在免疫力低下。颅脑 MRI 及视频脑电图均提示异常,全外显子检测发现其 KCNC2 基因存在未报道的 c.1829A>G(p.Asn610Ser)杂合突变,来源于母亲,符合常染色体显性遗传规律,确诊为发育性癫痫性脑病 103型。文献复习显示,42例相关患儿中76.2%有癫痫发作、54.8%发育迟滞,多数可存活。本病例拓展了KCNC2基因突变的致病位点与表型谱,为该病早期诊断与治疗提供参考。
We report a case of a 10-month-old male proband admitted for afebrile seizures, accompanied by intellectual and motor developmental delay. Despite multiple antiepileptic drug adjustments, seizures persisted, and the patient also had immune deficiency. Cranial MRI and video electroencephalography both indicated abnormalities. Whole-exome sequencing identified an unreported heterozygous KCNC2 mutation c.1829A>G (p.Asn610Ser), which was inherited from his mother and consistent with an autosomal dominant inheritance pattern. The patient was diagnosed with developmental and epileptic encephalopathy type 103. A literature review showed that among 42 relevant cases, 76.2% had seizures, 54.8% had developmental delay, and most patients survived. This case expands the pathogenic mutation spectrum and phenotypic profile of KCNC2 gene mutations, providing a reference for the early diagnosis and treatment of this disease.
[1] Huo L, Wu Q, Yang F, Liu X, Yang Z, Wang H. Novel KCNC2 variant associated with developmental and epileptic encephalopathy. Int J Dev Neurosci. 2023;83(4):357-367.
[2] Clatot J, Currin CB, Liang Q, et al. A structurally precise mechanism links an epilepsy-associated KCNC2 potassium channel mutation to interneuron dysfunction. Proc Natl Acad Sci U S A. 2024;121(3):e2307776121.
[3] Wang S, Yu Y, Wang X, et al. Emerging evidence of genotype-phenotype associations of developmental and epileptic encephalopathy due to KCNC2 mutation: Identification of novel R405G. Front Mol Neurosci. 2022;15:950255. Published 2022 Aug 25.
[4] Li L, Liu Z, Yang H, et al. Investigation of novel de novo KCNC2 variants causing severe developmental and early-onset epileptic encephalopathy. Seizure. 2022;101:218-224.
[5] Seiffert S, Pendziwiat M, Hedrich UBS, Helbig I, Weber Y, Schwarz N. KCNC2 variants of uncertain significance are also associated to various forms of epilepsy. Front Neurol. 2023;14:1212079. Published 2023 Jun 9.
[6] Vetri L, Calì F, Vinci M, et al. A de novo heterozygous mutation in KCNC2 gene implicated in severe developmental and epileptic encephalopathy. Eur J Med Genet. 2020;63(4):103848.
[7] Rydzanicz M, Zwoliński P, Gasperowicz P, et al. A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy. Am J Med Genet A. 2021;185(11):3384-3389.
[8] Li P, Butler A, Zhou Y, Magleby KL, Gurnett CA, Salkoff L. Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy. Front Pharmacol. 2025;15:1528541. Published 2025 Jan 15.
[9] Schwarz N, Seiffert S, Pendziwiat M, et al. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants. Neurology. 2022;98(20):e2046-e2059.
[10] Mehinovic E, Gray T, Campbell M, et al. Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy characterized by long-read sequencing. Am J Med Genet A. 2022;188(7):2071-2081.
[11] Hwang JY, Lee HJ, Go MJ, et al. An integrative study identifies KCNC2 as a novel predisposing factor for childhood obesity and the risk of diabetes in the Korean population. Sci Rep. 2016;6:33043. Published 2016 Sep 14.
[12] Rochtus A, Olson HE, Smith L, et al. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort. Epilepsia. 2020;61(2):249-258.
[13] Workalemahu T, Clark EAS, Madsen MJ, et al. Mapping genetic susceptibility to spontaneous preterm birth: analysis of Utah pedigrees to find inherited genetic factors. Am J Obstet Gynecol. 2025;232(6):557.e1-557.e10.
[14] Goncharova IA, Zarubin AA, Shipulina SA, et al. Mol Biol (Mosk). 2024;58(3):414-424.
[15] Boda E, Hoxha E, Pini A, Montarolo F, Tempia F. Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimer's disease. J Mol Neurosci. 2012;46(3):606-615.